Tag:
Asenapine
Latest Headlines
Latest Headlines
Schering gains blockbuster Saphris approval
Schering-Plough has won FDA approval of Saphris, a likely blockbuster antipsychotic, just ahead of its acquisition by Merck. The drug is now approved to treat episodes related to bipolar I disorder
FDA panel backs Schering-Plough antipsychotic
Schering-Plough took another big step in its quest to gain marketing approval for the antipsychotic blockbuster asenapine, winning the backing of an expert panel in a lopsided vote. The panel voted 9
FDA wants more data on Schering's Saphris
Regulators at the FDA presented Schering-Plough with a new obstacle for Saphris, its experimental therapy for schizophrenia and bipolar disorder, declining to give it an approval. But the agency did
Schering-Plough buoyed by asenapine data
Researchers say that Organon's asenapine was just as effective in controlling episodes of acute mania in two late-stage trials as Eli Lilly's Zyprexa --a drug widely considered the gold standard for
